Mitochondrial uncouplers have the capacity of passively shuttling protons from the mitochondrial intermembrane space to the mitochondrial matrix, independent of ATP synthase. This results in the disruption of oxidative phosphorylation and increased rate of metabolism as a counter action from the mitochondria. Therefore, small molecule mitochondrial uncouplers have potential for the treatment of obesity, diabetes, non-alcoholic fatty liver disease (NAFLD), neurodegenerative disorders, amongst others. A one-pot method for the synthesis of 1H-imidazo[4,5-b]pyrazines from [1,2,5]oxadiazolo[3,4-b]pyrazines is herein disclosed. In the presence of Fe, Yb(OTf)3, and the desired electrophile partner, in situ reduction of the oxadiazole fragment followed by cyclization afforded imidazolopyrazines in moderate to good yields. The selection of different orthoesters as electrophiles also allowed functionalization on the 2-position of the imidazole ring. This new method was used to synthesize 1H-imidazo[4,5-b]pyrazines to perform structure-activity relationship studies. Thus, a library of 75 compounds was synthesized and characterized for mitochondrial uncoupling activity. The biological activity of the compounds was demonstrated in oxygen consumption rate assays affording potent mitochondrial uncouplers. The method was further applied to the synthesis of 5-alkoxy-2-(trifluoromethyl)-1H-imidazo[4,5-b]pyrazin-6-amines, with over 50 derivatives synthesized. A structure-activity relationship study was performed using a variety of substituents to fine-tune the scaffold's potency. The installation of a methoxy group at the 5-position of the scaffold resulted in the discovery of compound 4.3.20, which exhibited the best activity with an EC50 of 3.6 ± 0.4 μM in rat L6 myoblasts and a half-life of 4.4 h in mice. Compound 4.3.20 displayed potential as an anti-obesity agent in a mouse model with an effective dose of 50 mg kg-1 without changes in food intake or lean mass. Tissue distribution studies revealed predominance in the liver and both white and brown adipose tissue. In addition, 4.3.20 improved serum markers of insulin sensitivity and hyperlipidemia such as insulin, glucose, triglycerides, cholesterol, and HOMA-IR. Taken together, compound 4.3.20 and related mitochondrial uncouplers show promise for further development in the treatment of obesity and other diseases. / Doctor of Philosophy / The mitochondria, which is an organelle within our cells, is where all the nutrients ingested in the form of food are metabolized, and either used for energy or stored as fat if they are not used. The latter is the main cause of obesity, carrying with it a myriad other comorbidities, such as high blood pressure, heart disease, diabetes, certain types of cancer. Obesity has become a great concern with an incidence of 42% in the US. Mitochondrial uncouplers are molecules that target the mitochondria with a mechanism of action of converting some of the energy ingested in the form of nutrients to be lost as heat instead of being stored as fat. The potential result is a regulated form of weight-loss. Herein, we developed a method for the synthesis of a novel mitochondrial uncoupler scaffold and disclose the mitochondrial uncoupler activity of over 150 molecules. In particular, compound 4.3.20 was tested in an obesity mouse model and was shown to induce fat loss with mice fed a high fat diet. Our investigations support potential use of mitochondrial uncouplers as a mechanism for the treatment and prevention of obesity and other metabolic diseases.

Aerosols play important roles in atmospheric and environmental processes. Not only do they impact human health, they also affect visibility and climate. Despite recent advances made to under their sources and fate, there remains a limited understanding of the mechanisms that lead to the formation of aerosols and their ultimate fate in the atmosphere. These knowledge gaps provide the crux of the research reported herein, which has focused on identifying novel sources of atmospheric aerosol, characterizing its physical and optical properties, and rationalizing these properties using an in-depth knowledge of the molecular level mechanisms that led to its formation. Upon mowing, turfgrasses emit large amounts of green leaf volatiles which can then be oxidized by ozone to form SOA. Overall, the mowing of lawns has the potential to contribute nearly 50 µg SOA per square meter of lawn mowed. This SOA contribution is on the same order of magnitude as other predominant SOA sources (isoprene, monoterpenes, sesquiterpenes). Turfgrasses represent an interesting and potentially meaningful SOA source because they contribute to SOA and also because they cover large land areas in close proximity to oxidant sources. Another related SOA precursor is sugarcane, which is in the same family as turfgrass and is among the largest agricultural crops worldwide. Globally, the ozonolysis of sugarcane has the potential to contribute 16 Mg SOA to the atmosphere, compared to global estimates of SOA loading that range from 12-70 Tg SOA. In order to fully understand the role of atmospheric SOA on the radiative budget (and therefore climate), it is also important to understand its optical properties; its ability to absorb vs scatter light. Turfgrass and sugarcane produced SOA that was weakly absorbing while its scatter efficiency was wavelength and size-dependent. Interestingly, SOA formed under both dry (10% RH) and wet (70% RH) conditions had the same bulk chemical properties (O:C), yet significantly different optical properties, which was attributed to differences in molecular-level composition. The work presented herein represents a unique, inclusive study of SOA precursors. A complete understanding of the chemistry leading to SOA formation is used to understand its physical and optical properties and evaluate these large-scale effects of SOA from these precursors.

The overall aim of this work was to apply HINT, an empirical scoring function based on the understanding of hydrophobicity, to analyze and predict the binding affinities and biological activities of colchicine-site anticancer agents. The second, concurrent aim was to improve the scoring function by incorporating tautomerism within the modeling process. Our belief is that proper evaluation of tautomeric forms for small molecules will improve performance of virtual screening. The novel pyrrole-based compounds targeting the colchicine site were docked into the receptor using HINT as a rescoring function. Two distinct binding modes dictated by the size and shape of a subpocket were predicted to differentiate the highly active compounds from the weak ones. Of the residues predicted to participate in binding for the active binding mode, Cys241β was revealed to form a weak but critical hydrogen bond with the ligand. A larger collection of colchicine-site agents, biologically tested in the same laboratory including our pyrrole-based compounds were subject to 3D quantitative structure-activity relationship (QSAR) study. Using results on docking the pyrrole compounds as a guide, relative binding poses and QSAR models were built to facilitate ligand design and optimization. A new 3D modeling approach was introduced to visually highlight the unique features of highly active compounds and the commonality of all compounds in the dataset using HINT maps and successfully tested on the colchicine-site agents. These results will provide valuable guidance in the future design and development of new colchicine-site agents. To incorporate tautomerism within HINT, we proposed and developed two workflow approaches: a general search tool using a simple and intuitive algorithm analyzing hydrogen shift patterns to identify and enumerate tautomeric structures, and a database that contains commonly observed tautomeric structures. The first approach was designed for small-scale docking studies and the second approach was designed for large-scale virtual screening. The tautomer module in HINT will give more accurate modeling results when the compound encountered is able to tautomerize.

Methcathinone (MCAT) is the β-ketone analog of methamphetamine, and like its amphetamine analog, MCAT functions as a monoamine releaser that selectively promotes the release of dopamine (DA) and norepinephrine (NE) over serotonin (5-HT). MCAT produces amphetamine-like psychostimulant effects and is classified as a Schedule I drug of abuse by the United States Drug Enforcement Administration (DEA). Recently, synthetic MCAT analogs have emerged as designer drugs of abuse in Europe and the United States and have been marketed under deceptively benign names like “bath salts” in an attempt to evade legal restriction. These dangerous, recently emergent and novel drugs of abuse display varying selectivity to promote release of DA/NE vs. 5-HT, and selectivity for DA neurotransmission is believed to correlate with abuse liability. The goal of this dissertation was to conduct preclinical research to examine structural determinants of abuse-related behavioral and neurochemical effects produced by a series of synthetic MCAT analogs. Specifically, this project focused on one feature of the methcathinone scaffold: the para substituent of the benzene ring. A series of six novel MCAT analogs will be examined to evaluate how physicochemical parameters (steric, Es; electronic, σp; lipophilic, πp) of the para substituent influence in vitro monoamine transporter selectivity as well as in vivo neurochemical and behavioral effects. Results from this body of work implicate steric factors as being particularly important in determining a compound’s abuse-related neurochemical and behavioral effects. Thus, these data not only offer an improved understanding of the mechanism of abuse-related drug effects produced by synthetic MCAT analogs, but also help in the generation of homology models of the human DA and 5-HT transporters (DAT and SERT, respectively).

京都大学 / 0048 / 新制・課程博士 / 博士(薬科学) / 甲第22397号 / 薬科博第119号 / 新制||薬科||13(附属図書館) / 京都大学大学院薬学研究科薬科学専攻 / (主査)教授 髙倉 喜信, 教授 山下 富義, 教授 小野 正博 / 学位規則第4条第1項該当 / Doctor of Pharmaceutical Sciences / Kyoto University / DFAM

Sigma receptors originally thought to be an opioid receptor is now categorized as a distinct class of receptor. There are two main subtypes, the sigma-1 receptor and an uncharacterised binding site, named the sigma-2 binding site. The presence of the sigma-2 binding site shows high correlation with proliferation of cells and is associated with cancer. I have categorized sigma-1 and sigma-2 binding sites in 11 human tumour cell lines. I have demonstrated that tumour cell lines from a range of tissues express both sigma-1 and sigma-2 binding sites. One exception is the MCF7 breast cancer cell line, which lacks sigma-1 receptors. I show that the quantitation of sigma-2 binding sites using the "masking" protocols are flawed, significantly overestimating levels of sigma-2 binding sites. I propose novel protocols to determine levels of sigma-1 receptors and sigma-2 binding sites in cell lines and tissue. Using radioligand binding assays in MCF7 cells, I have characterised novel sigma-2 ligands. These ligands are simple ammonium salts containing a single nitrogen atom. They are simpler than the previously recognised pharmacophore for the sigma-2 site. I have shown that these simple ammonium salts show graded affinity for the sigma-2 binding site. The highest affinity ligands were dihexylammonium (pKi 7.58) and dioctylammonium (pKi 7.9). I have used these ammonium salts and previously characterised ligands to determine sigma-2 binding site biology. I have shown that the biological activity of these drugs is related neither to their hydrophobicity nor their ability to effect calcium signalling in cells. I propose that the Hill slope of binding is inversely related to the efficacy of a ligand to inhibit metabolic activity of cancer cells. Furthermore, I offer an explanation as to why concentrations of sigma-2 ligands far higher than their determined binding affinities are required to inhibit metabolic activity.

Os neutrófilos são células fagocíticas do sistema imune inato com mecanismos especializados de digestão de patógenos, complexos imune e detritos celulares, que são mediados principalmente por espécies reativas de oxigênio (EROs) e enzimas proteolíticas. Entretanto, a ativação maciça de neutrófilos leva a uma liberação exacerbada de enzimas e EROs para o meio extracelular, o que pode ultrapassar a capacidade de defesa tecidual, composta por antioxidantes e antiproteinases, e lesar o tecido, bem como amplificar o processo inflamatório observado em algumas doenças inflamatórias, autoimunes e infecciosas. O envolvimento de neutrófilos na fisiopatologia de tais doenças tem atraído o interesse na pesquisa de novas substâncias com propriedades antioxidantes e imunomodulatórias. Neste trabalho, foi avaliado o efeito modulatório de onze derivados de cumarinas hidroxiladas e acetoxiladas sobre duas funções efetoras de neutrófilos humanos (produção de EROs e desgranulação), bem como a citotoxicidade dessas substâncias. Além disso, a relação estrutura-atividade foi analisada. Para tais investigações, o sangue venoso foi coletado de voluntários saudáveis e os neutrófilos foram isolados pelo método da gelatina. O metabolismo oxidativo dos neutrófilos foi desencadeado por zimosan opsonizado com soro humano normal (ZIops) ou forbol-12-miristato-13-acetato (PMA), e a resposta celular foi avaliada pelos ensaios de quimioluminescência dependente de lucigenina (QLluc) ou de luminol (QLlum). Para a realização desses ensaios, foram padronizadas as seguintes condições experimentais: concentração das sondas luminol e lucigenina; concentração do solvente dimetilsulfóxido; tempo de leitura da QLuc e QLlum. Posteriormente, a atividade antioxidante das cumarinas frente ao radical 2,2-difenil-1-picrilhidrazil (DPPH) foi avaliada espectrofotometricamente em 510 nm. Além disso, foi avaliado o efeito das cumarinas na desgranulação dos neutrófilos induzida por n-formil-metionil-leucil-fenilalanina (fMLP), utilizando-se a enzima elastase como marcador, bem como o efeito dessas substâncias na atividade da elastase liberada pelos neutrófilos. Ambos os ensaios foram realizados através da quantificação de p-nitroanilina liberada após a quebra de um substrato específico para essa enzima, em 405 nm. A toxicidade das cumarinas sobre os neutrófilos foi avaliada pela exclusão do azul de tripan e pela medida da liberação de lactato desidrogenase. Observou-se que, tanto para as células estimuladas por ZIops quanto por PMA: (i) a maioria das cumarinas inibiu a QLluc e a QLlum de maneira dependente da concentração, sendo que as mais ativas (C, D) possuíam grupos orto-diidroxi; (ii) quatro cumarinas (A, B, F, G) inibiram a QLluc, mas aumentaram a QLlum; (iii) a cumarina não-substituída (K) não teve efeito modulatório significativo sobre a QLlum ou QLluc; (iv) ordem de efeito inibitório das demais substâncias (E, H, I, J) foi dependente do número e posição dos grupos substituintes, bem como do tipo de sonda quimioluminescente (luminol ou lucigenina) e do estímulo utilizado. Verificou-se também que três cumarinas (C, D, H) tiveram atividade antioxidante significante frente ao radical livre DPPH. Além disso, quatro das substâncias avaliadas (A, B, E, G) inibiram a desgranulação dos neutrófilos, mas nenhuma delas (A - K) interferiu na atividade da elastase. A análise do conjunto de resultados obtidos sugere que o número e posição dos grupos hidroxil e acetil no esqueleto cumarínico foram importantes para a modulação do metabolismo oxidativo de neutrófilos humanos, sendo que, dependendo do tipo de EROs medida, tais características estruturais podem levar a um efeito anti- ou pró-oxidante. Além disso, o efeito modulatório das cumarinas sobre as funções efetoras dos neutrófilos foi dependente o tipo de estímulo utilizado, e não foi mediado pela toxicidade dessas substâncias, nas condições ensaiadas. Sendo assim, os resultados obtidos podem auxiliar no entendimento dos requisitos estruturais das cumarinas necessários para uma modulação eficiente das funções efetoras dos neutrófilos envolvidas em doenças inflamatórias. / Neutrophils are phagocytic cells from the innate immune system with highly developed mechanisms for intracellular digestion of pathogens, immune complexes and cell debris, which are mainly mediated by reactive oxygen species (EROs) and proteolytic enzymes. However, massive neutrophil activation lead to release of large amounts of enzymes and EROs to the extracellular milieu, that may overpower the tissue defense systems, composed of antioxidants and antiproteinases, and damage the tissue, as well as contribute to the amplification of the inflammatory process found in some inflammatory, autoimmune and infectious diseases. The involvement of neutrophils in the physiopathology of such diseases has attracted the interest in the search of new compounds with antioxidant and immunomodulatory properties. In this work, we evaluated the modulatory effect of eleven hydroxylated and acetoxylated coumarin derivatives in two effector functions of human neutrophils (EROs production and degranulation) as well as the cytotoxic effects of these compounds. In addition, the structure-activity relationship was analyzed. Venous blood was collected from healthy volunteers and neutrophils were isolated by the gelatin method to perform our experiments. The neutrophil oxidative metabolism was triggered by normal human serum-opsonized zymosan (ZIops) or phorbol-12-myristate-13-acetate (PMA), and the cellular response was evaluated by the lucigenin (QLluc)- or luminol (QLlum)-amplified chemiluminescence assays. In order to conduct this study, the following experimental conditions had to be established: concentration of the chemiluminescence probes luminol and lucigenin; concentration of the solvent dimethylsulfoxide; the QLluc and QLlum reaction time. Afterwards, the antioxidant activity against 2,2-diphenyl-1-picrylhydrazyl radical (DPPH) was evaluated spectrophotometrically at 510 nm. Moreover, the effect of coumarins in the n-formyl-metionyl-leucyl-phenylalanine (fMLP)-induced neutrophil degranulation was evaluated by using elastase as marker, and the effect of these compounds in the elastase activity were also evaluated. Both assays were performed by measuring the elastase-mediated p-nitroaniline release from a specific substrate (405 nm). Toxicity of coumarins to the neutrophils was evaluated by trypan blue exclusion and measurement of lactate dehydrogenase release. Considering both, ZIops and PMA-stimulated neutrophils, we observed that: (i) most of coumarins inhibited the QLluc and the QLlum in a concentration-dependent manner, being the orto-dihydroxylated (C, D) the most active ones; (ii) four coumarins (A, B, F, G) inhibited the QLluc but increased the QLlum; (iii) the unsubstituted coumarin (K) had no significant modulatory effect on QLlum or QLluc; (iv) the rank order of inhibitory effect among the other compounds (E, H, I, J) was dependent on the number and position of substituents, as well as the type of chemiluminescent probe (luminol or lucigenin) and stimulus used. In addition, we observed that three coumarins (C, D, H) had a significant antioxidant activity against DPPH, and four compounds (A, B, E, G) inhibited the neutrophil degranulation, but none of the tested coumarins (A - K) interfered in the elastase activity. Taken together, our results suggest that the number and position of the hydroxyl and acetyl groups in the coumarin moiety were important to modulate the human neutrophil oxidative metabolism. Depending on the type of EROs measured, such structural features can lead to an anti- or pro-oxidant effect. Furthermore, the modulatory effect of coumarins on the neutrophil effector functions was dependent on the type of stimulus used, but it was not mediated by toxicity of these compounds to the neutrophils, under the assessed conditions. Therefore, the results described herein may be helpful to understand the structural requirements of coumarins to reach an efficient modulation of the neutrophil effector functions involved in inflammatory diseases.

A formação de complexos antígeno-anticorpo ou imunocomplexos (ICs) na circulação e sua eliminação faz parte dos mecanismos de defesa imune humoral do ser humano. Em algumas patologias, como lupus eritematoso sistêmico, artrite reumatóide e vasculite auto-imune, ocorre um desequilíbrio nesse processo, que leva à deposição dos ICs nos tecidos e ao desencadeamento de uma reação inflamatória. Esta, por sua vez, envolve o recrutamento e ativação de neutrófilos, que têm importante participação na patogênese dessas doenças. A ativação dos neutrófilos pelos ICs, via receptores para a porção Fc de IgG (FcR) e receptores de complemento (CR), desencadeia diversas funções efetoras, tais como fagocitose, desgranulação e o metabolismo oxidativo, com a produção de espécies reativas de oxigênio (EROs). Estas funções estão envolvidas na digestão dos ICs, na morte de microorganismos, e na regulação do processo inflamatório. Entretanto, nas doenças mediadas por ICs, os neutrófilos ativados liberam grandes quantidades de enzimas e EROs para o meio extracelular, contribuindo para a lesão dos tecidos do hospedeiro e a amplificação do processo inflamatório. Neste trabalho foi avaliado o efeito modulatório de vinte derivados de 3-fenilcumarina nas funções de neutrófilos estimulados por ICs de ovalbumina (OVA) e IgG anti-OVA. Além disso, foi feita a investigação mecanismos de ação dessas substâncias e a análise da relação estrutura-atividade. O metabolismo oxidativo dos neutrófilos ativados por ICs foi medido por ensaio de quimioluminescência dependente de lucigenina ou de luminol (QLlucPMN e QLlumPMN, respectivamente). Observou-se que as 3-fenilcumarinas contendo o grupo substituinte 3,4-metilenodioxi e o grupo substituinte 6,7-orto-diidroxi (C13) ou 6,7-orto-diacetoxi (C13a), bem como a 3-fenilcumarina 6,7,3,4-tetraacetoxilada (C24a), apresentaram atividade inibitória maior que a quercetina (QUER) sobre a QLlucPMN e a QLlumPMN. Para as demais substâncias avaliadas, que foram tão ou menos ativas que a QUER, as características estruturais relacionadas à inibição da QLlucPMN foram um pouco diferentes daquelas relacionadas à inibição da QLlumPMN. Além disso, as 3-fenilcumarinas estudadas e a QUER não apresentaram efeito tóxico sobre os neutrófilos, avaliado pela liberação de lactato desidrogenase e pelo ensaio de exclusão ao corante Azul de Tripan, nas condições empregadas. Para as três 3-fenilcumarinas que apresentaram maior efeito inibitório sobre o metabolismo oxidativo dos neutrófilos (C13, C13a e C24a), o aumento do tempo de pré-tratamento levou a uma tendência de redução do efeito inibitório da substância C24a, mas não influenciou na atividade biológica das substâncias C13 e C13a. Essas três substâncias não interferiram na capacidade fagocítica das células, avaliada por microscopia eletrônica de transmissão. Para todas as 3-fenilcumarinas foi avaliada também a capacidade antioxidante frente ao radical livre 2,2-difenil-1-picril-hidrazil e o efeito inibitório dessas substâncias sobre a quimioluminescência produzida pela reação horseradish peroxidase-H2O2-luminol (QLHRP). Foi observado que a QUER e as 3-fenilcumarinas contendo o grupo substituinte orto-diidroxi (C13, C23, C24) tiveram atividade antioxidante e inibiram a QLHRP, mas suas análogas acetoxiladas (C13a, C23a, C24a), bem como as demais substâncias avaliadas, foram significativamente menos ativas nesses modelos experimentais não celulares. O conjunto de resultados deste trabalho sugere que as atividades biológicas das 3-fenilcumarinas estudadas foram dependentes de suas estruturas químicas, e pequenas modificações nestas podem levar a alterações significativas na magnitude de seus efeitos biológicos. Além disso, tanto a lipofilicidade das substâncias quanto a sua capacidade antioxidante parecem ser relevantes para a modulação eficiente do metabolismo oxidativo dos neutrófilos e da conseqüente lesão tecidual. / Formation and clearance of circulating antigen-antibody complexes or immune complexes (ICs) take part in the humoral immune defense mechanisms. In some diseases, as systemic lupus erythematosus, rheumatoid arthritis and auto-immune vasculitis, an imbalance of this process occurs, leading to the ICs deposition within tissues and triggering an inflammatory reaction. The last one involves the recruitment and activation of neutrophils, which have an important role in the pathogenesis of such diseases. Neutrophil activation by ICs, via receptors for the Fc portion of IgG (FcgR) and complement receptors (CR), triggers a sort of effector functions, such phagocytosis, degranulation and the oxidative metabolism, which produces reactive oxygen species (ROS). These functions are involved in the ICs digestion, microbial killing and the inflammatory process regulation. However, the activated neutrophils release large amounts of enzymes and ROS to the extracellular milieu, contributing to the tissue damage and amplification of the inflammatory process in the IC-mediated diseases. In this work, we evaluated the modulatory effect of twenty 3-phenylcoumarin derivatives in the neutrophil functions stimulated by ICs of ovalbumin (OVA) and IgG anti-OVA. In addition, the mechanisms of action of these compounds were investigated, and the structure-activity relationship was analyzed. The IC-activated neutrophil oxidative metabolism was measured by lucigeninor luminol-dependent chemiluminescence assay (CLlucPMN and CLlumPMN, respectively).It was observed that the 3-phenylcoumarins bearing a 3,4-methylenodioxy and the 6,7-orto-dihydroxy (C13) or the 6,7-orto-diacetoxy (C13a) group, as well as the 6,7,3,4-tetraacetoxylated 3-phenylcoumarin (C24a), inhibited CLlucPMN and CLlumPMN more than quercetin (QUER). Regarding the other evaluated compounds, whose inhibitory effects were similar to or lower than QUER, the structural features related to the CLlucPMN inhibition were different from those related to the CLlumPMN inhibition. Moreover, the studied 3-phenylcoumarins and QUER had no toxic effects on neutrophils, as evaluated by lactate dehydrogenase release and Trypan Blue exclusion, under the assessed conditions. With respect to the three 3-phenylcoumarins that had the highest inhibitory effects on the neutrophil oxidative metabolism (C13, C13a and C24a), the increase of the cell pre-treatment period showed a tendency to decrease the inhibitory ability of compound C24a, but did not influence the biological activity of compounds C13 and C13a. These three compounds did not interfere in the neutrophil phagocytic ability, as evaluated by transmission electron microscopy. The antioxidant activity against the 2,2-diphenyl-1-picrylhydrazyl free radical and the inhibitory effect in the chemiluminescence generated by the horseradish peroxidase-H2O2-luminol reaction (CLHRP) were evaluated for all 3-phenylcoumarins. It was found that QUER and those 3-phenylcoumarins bearing the orto-dihydroxy group (C13, C23, C24) had antioxidant activity and inhibited the CLHRP. However, their acetoxylated analogues (C13a, C23a, C24a) and the other evaluated compounds were significantly less active on these cell-free experimental models. Taken together, the results of the present work suggest that the biological activities of the 3-phenylcounarins here investigated were dependent on their chemical structures, and small changes on the molecule can lead to significant changes on the magnitude of their biological effects. Moreover, both lipophilicity and antioxidant capacity of these compounds seem to be relevant to an efficient modulation of the neutrophil functions and the consequent tissue damage.

Previous research showed that the C-terminal tail of TCS can be deleted to generate a mini-TCS (C7-TCS) with antigenicity. The second topic of my study is to resolve the role of the C-terminal of TCS. Structure of C7-TCS showed that deletion of the C-terminal tail destabilizes the protein structure and makes Trp192 more solvent exposed. The relationship between the C-terminal tail and Trp192 was determined by mutating Trp192 to Phe in wild-type TCS and C7-TCS, generating W192F-TCS and W192F-C7-TCS. The crystal structure of C7-TCS, [W192F]-TCS and [W192F]-C7-TCS were determined and compared. Trp192 was identified as an important residue in stabilizing the conformation of TCS. Besides, the accumulative effect of Trp192 and the C-terminal tail is significant on the ribosome-inactivating activity. By comparing the structures, it was found that, the hydrogen bond formed by amino acids 240 and 35 seems to be essential for the structure and amino acid 240 should be a critical residue for the connection of the N-terminal and C-terminal domains in trichosanthin. / Ribosome-inactivating activity is the most important activity of TCS and RIPs. Therefore, the third topic of my study is to find the important of interaction between TCS and ribosomal proteins. Two ribosomal proteins, P0 and P1, have been identified previously to interact with TCS. By yeast two-hybrid screening, three cut of ten charge residues in TCS were identified to be the interaction sites between TCS and ribosomal protein P0. The interaction region was located on the surface of TCS near the entrance to the active pocket. The interaction with P0 was shown to be carried out by electrostatic interaction between the positively charge residues of TCS. However, the mutation of all the concerned residues in TCS gave only a mild reduction in inhibiting the protein synthesis of an in vitro reticulocyte translation system, showing that the interaction between TCS and P0 only plays a minor role in the ribosomal inactivating activity of TCS. / The first topic of my research is to find the role of Glu-85. The structure of [E85Q]-TCS and AMP complex was obtained. It is deduced that there are two sites for substrate binding in TCS, one is for recognition and another ion hydrolysis. The structure also indicated that protonation of substrate adenine is carried out by a water molecule in the active pocket of TCS during its N-glycosidase action. / Trichosanthin (TCS) is a Chinese medicinal protein isolated froth the root tuber of Trichosanthes kirilowi Maximowicz. It is a 27kDa protein with multiple pharmacological properties, including abortifacient, anti-tumor and anti-human immunodeficiency virus (HIV). It is believed that the pharmacological properties of TCS are related to ribosome-inactivation, by breaking, the specific glycosidic bond of adenine 4324 from the 28S rRNA. / Too Hiu Mei. / "February 2006." / Advisers: Pang-Chui Shaw; Kam-Bo Wong. / Source: Dissertation Abstracts International, Volume: 67-11, Section: B, page: 6213. / Thesis (Ph.D.)--Chinese University of Hong Kong, 2006. / Includes bibliographical references (p. 164-175). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Electronic reproduction. [Ann Arbor, MI] : ProQuest Information and Learning, [200-] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Abstracts in English and Chinese. / School code: 1307.

Synthetic cathinones are stimulant drugs of abuse that act at monoamine transporters e.g. the dopamine transporter (DAT) as releasing agents or as reuptake inhibitors. More than >150 new synthetic cathinones have emerged on the clandestine market and have attracted considerable attention from the medical and law enforcement communities. threo-Methylphenidate (tMP) is an FDA approved drug for the treatment of ADHD and narcolepsy, which also acts as a DAT reuptake inhibitor and is widely abused. tMP and synthetic cathinones share some structural similarities and extensive structure-activity relationship (SAR) studies on tMP have been conducted. However, much less is known about the SAR of synthetic cathinones, and the available MP literature might assist in understanding it. The main focus of this research was to compare SAR between methylphenidate-cathinone hybrids and available methylphenidate SAR in order to identify some guiding principles that might allow
us to predict their abuse potential and to identify which cathinones should be
targeted for more extensive evaluation. In the present study, we evaluated eight 2-benzoylpiperidine analogs and a descarbonyl analog to determine if tMP SAR can be applied to cathinone SAR. We conducted molecular modeling and docking studies and predicted the order of potency to be tMP > 2-benzoylpiperidine > 2-benzylpiperidine based on the number of hydrogen bonds. The synthesized analogs were evaluated in a competition assay using live-cell imaging against APP+ in HEK293 cells stably expressing hDAT. All compounds were found to be DAT reuptake inhibitors and, as the modeling studies predicted, the order of potency in our functional studies was also found to be tMP > 2-benzoylpiperidine > 2- benzylpiperidine. A significant correlation was obtained between the potency of the benzoylpiperidines and tMP binding data (r = 0.91) suggesting that the SAR of tMP analogs might be applicable to the synthetic cathinones as DAT reuptake inhibitors.